Description
MRP8/14 is a serum that is predictive of response to methotrexate, when started as a single DMARD for arthritis, and relapse if methotrexate is stopped (in those who have reached clinical remission on MTX) in juvenile idiopathic arthritis (JIA), see Foell et al JAMA 2010 (1), and Moncrieffe et al Rheumatology 2013.
Also known as
MRP8
Request a test
Complete the attached form
Additional information
Not applicable
Sending address
Immunology Department
Level 4, Camelia Botnar Laboratories
Great Ormond Street Hospital
Great Ormond Street
WC1N3JH